[The prediction of the late effect of charcoal hemoperfusion in rheumatoid arthritis patients].
Hemocarboperfusion is effectively used for the treatment of serious cases of rheumatoid arthritis (RA). The effectiveness of the treatment may be decreased by possible development of the rebound syndrome (RS) after the treatment. The useful retrospective frequency analysis does not often allow predicting the development of RS. The authors devised the system of forecasting the development of RS depending on the body state by means of an analysis of the results in the group of 38 patients with classical RA treated by hemocarboperfusion. They also designed a statistical model with the help of linear regression and correlation methods. It allows counting the degree of the predisposition to RS development for each patient both numerically and individually. The precision of the conclusion based on the method is about 90%. The results of the forecasting give the general characteristics of RA development and can be used as an additional argument for prescription of hemocarboperfusion.